
|Podcasts|June 17, 2022
Pharmacy Focus: Psychedelic Pharmacy - Psilocybin-Assisted Therapy for Binge Eating Disorder
Jim Gilligan, PhD, discusses a phase 2 study investigating psilocybin-assisted therapy for binge eating disorder.
Advertisement
This month, we spoke with Jim Gilligan, PhD, to learn about a phase 2 study investigating the use of psilocybin-assisted therapy for the treatment of binge eating disorder.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Ensitrelvir for Post-Exposure Prophylaxis of COVID-19 in Adolescents and Adults
2
What Pharmacists Need to Know About Retatrutide's TRIUMPH-1 Phase 3 Results
3
Why Some Patients Do Not Respond to GLP-1 Therapies
4
GIRE Combination Shows PFS Benefit in First-Line Metastatic Breast Cancer Treatment, Earning FDA Priority Review
5








































































































































